Recursion Pharmaceuticals (RXRX) Reports Q3 Loss, Misses Revenue Estimates

Recursion Pharmaceuticals (RXRX) delivered earnings and revenue surprises of +5.26% and -70.34%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for ...

Recursion Pharma Names Najat Khan to Succeed Chris Gibson as President, CEO

Recursion Pharmaceuticals has designated its top research executive, Najat Khan, to succeed co-founder Chris Gibson as president and chief executive of the clinical-stage biotechnology company, ...
STAT

Recursion CEO Chris Gibson out as company head after 12 years

Recursion CEO Chris Gibson is out after 12 years as the ambitious ‘techbio’ company positions itself for its next phase of AI ...
TipRanks on MSN

Recursion Pharmaceuticals Announces New CEO Appointment

Recursion Pharmaceuticals ( ($RXRX) ) has provided an update. Recursion Pharmaceuticals announced significant leadership changes effective January ...